Results from a Multicenter, Randomized, Double Blind, Placebo-Controlled Study of Repository Corticotropin Injection for Relapsing-Remitting Multiple Sclerosis
Background: Patients with relapsing-remitting multiple sclerosis (RRMS) may experience acute relapses that are nonresponsive (20-35%) to...
Improving Communication about Multiple Sclerosis: The MS-Support Decision Aid
Background: Good communication between patients and their health care provider (HCP) is essential for shared decision making (SDM). We...
Fatigue Evolution for Patients without Relapses on the Fsiq-RMS Symptoms Domain
Background: Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system that results in progressive and...
The Multiple Sclerosis at Home Access Program (MAHA): New Challenges for Those Living with Multiple Sclerosis and Significant Disability during the COVID-19 Pandemic
Background: Abundant evidence supports disparity in health care delivery for persons with disability. These disparities may be magnified...
Mucosal Associated Invariant T (MAIT) Cells Show Defective Activation in People with Multiple Sclerosis
Background: mucosal associated invariant T (MAIT) cells are innate-like T cells expressing an invariant TCR ? chain with a limited number...
Cerebrospinal Fluid Protein Is Higher in Males with Multiple Sclerosis: Results from an International Multicenter Cohort
Background: Sex has a differential effect on MS disease severity. Males tend to have a more severe clinical course and a greater tendency...